Regulus Therapeutics(RGLS-Q)NASDAQ
Today's Change
Real-Time Last Update
Pre Market Change
Pre Market Last Update
Volume
Current Target Price
High Target Price
Mean Target Price
Low Target Price
Median Target Price
Earnings Estimates
| Current Qtr09/2024 | Next Qtr12/2024 | Fiscal Yr12/2024 | Fiscal Yr12/2025 | |
|---|---|---|---|---|
| Average Estimate | -0.18 | -0.19 | -0.80 | -1.20 |
| Number of Estimates | 3 | 3 | 3 | 3 |
| High Estimate | -0.18 | -0.18 | -0.76 | -0.83 |
| Low Estimate | -0.19 | -0.20 | -0.84 | -1.88 |
| Prior Year | -0.40 | -0.40 | -1.58 | -0.80 |
| Growth Rate Est. (year over year) | +55.00% | +52.50% | +49.37% | -50.00% |
Earnings History - Surprises*
| Qtr Ending06/2024 | Qtr Ending03/2024 | Qtr Ending12/2023 | Qtr Ending09/2023 | |
|---|---|---|---|---|
| Reported | $-0.17 | $-0.29 | $-0.40 | $-0.40 |
| Estimate | $-0.17 | $-0.15 | $-0.40 | $-0.36 |
| Difference | unch | -0.14 | unch | -0.04 |
| Surprise | unch | -93.33% | unch | -11.11% |
* Earnings are based on GAAP income from continuing operations.
Average Analyst Ratings
Rating
Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell
# of Analysts
4.50
3 Mths Ago4
4.60
2 Mths Ago5
4.60
1 Mth Ago5
4.60
Current5
Ratings Values:
Strong Buy5
Moderate Buy4
Hold3
Moderate Sell2
Strong Sell1
Ratings Breakdown
| 3 Mths Ago | 2 Mths Ago | 1 Mth Ago | Current | |
|---|---|---|---|---|
| # of Analysts: | 4 | 5 | 5 | 5 |
3 | 4 | 4 | 4 | |
| Holds | 1 | 1 | 1 | 1 |
Key:
Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell